Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IL20RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANTXR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPCAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TACR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TDRD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP350 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAOK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSRNP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LNPEP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL6ST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on